Structure of Risperidal CAS 106266-06-2Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

106266-06-2

Name

Risperi­dal

Syn­onyms

106266-06-2 [RN] 3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on 3-{2-[4-(6-Fluor-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on [Ger­man] [ACD/IUPAC Name] 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)pipéridin-1-yl]éthyl}-2-méthyl-6,7,8,9-tétrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one [ACD/IUPAC Name] 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-pipéridinyl]éthyl}-2-méthyl-6,7,8,9-tétrahydro-4H-pyrido[1,2-a]pyrimidin-4-one [French] [ACD/IUPAC Name] 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- [ACD/​Index Name] 6085 Beliv­on [Trade name] L6UH7ZF8HC Risperdal [Trade name] Risperi­dal risperi­dona [Span­ish] [INN] Risperi­done [BAN] [INN] [JAN] [USAN] [Wiki] risperi­don­um [Latin] [INN] Rispen Spiron 1020719-76-9 [RN] 1026102-43-1 [RN] 158697-67-7 [RN] 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one 3-[2-[4-(6-fluoroindoxazen-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one 3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one 3-{2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one 3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(risperidone impu­ri­ty) 4891881 [Beil­stein] 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl- 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl- 4H-Pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl- 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benz-isoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- 70381-58-7 [RN] 9,9-dideuterio-3-[2-[4-(7-deuterio-6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-(trideuteriomethyl)-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Apex­i­done C23H27FN4O2 CID5073 D018967 Jsp000573 KS-1106 MFCD00274576 [MDL num­ber] MLS000759429 NCGC00094352-03 Phar­­makon1600-01506038 Psy­chodal R 62 766 R 64 766 R 64 766;Risperdal R 64,766 R64,766 R-64,766 R64766 R-64-766 R-64-766|R-64766|Risperdal® Risperdal (TN) Risperdal M Risperdal® risper­done Risperi­dal M-Tab Risperi­dal M-Tab (Trade name) Risperi­dal M-Tab ; Risperin ; Rispolept ; Rispolin ; Sequinan Risperi­dona Risperi­dona [Span­ish] Risperi­dona ; Risperi­don­um Risperi­done (JAN/USAN/INN) risperidone(r 64 766) Risperi­don­um Risperi­don­um [Latin] Risperin Risperin (Trade name) Rispolept Rispolept (Trade name) Rispolin Rispolin (Trade name) Sequinan SMR000466323 TL8000230 UNII :L6UH7ZF8HC UNII-L6UH7ZF8HC UV1164800

Mol­e­c­u­lar Structure

Structure of Risperidal CAS 106266-06-2

Struc­ture of Risperi­dal CAS 106266-06-2

SMILES

Cc1c(c(=O)n2c(n1)CCCC2)CCN3CCC(CC3)c4c5ccc(cc5on4)F

Std­InChI

InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3

Std­InChIKey

RAPZEA­P­ATH­NIPO-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C23H27FN4O2

Mol­e­c­u­lar Weight

410.49

MDL Number

MFCD00274576

Safe­ty Data

Sym­bol

exclamation-mark-jpgGHS06

Sig­nal Word

Dan­ger

Haz­ard Statements

H301

Pre­cau­tion­ary Statements

P301P310

Per­son­al Pro­tec­tive Equipment

Eye­shields, Faceshields, Gloves, type P2 (EN 143) res­pi­ra­tor car­tridges

RIDADR

UN 2811 6.1 / PGI­II

WGK Germany

RTECS

UV1164800

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Risperi­dal CAS 106266-06-2

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

EP, USP

GMP

LCF­DA

Basic Patent Situation

US expiry date20071229
EU expiry date20060313(20071207)
JP expiry date20181211

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the Anti-psy­­chot­ic

Links

This prod­uct is devel­oped by our R&D com­pa­ny Wat­son­noke Sci­en­tif­ic Ltd(http://​www​.wat​son​noke​.com/), and here is the cor­re­spond­ing linkhttp://​www​.wat​son​noke​.com/​r​i​s​p​e​r​i​d​a​l​-​c​a​s​-​1​0​6​2​6​6​-​0​6​-2/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the car.